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Abstract: This paper describes a new synthesis of (-)-swainsonine via the ring-
closing metathesis reaction of a substituted 3-allyl-4-vinyl-2-oxazolindinone and 
subsequent diastereoselective syn-dihydroxylation of the resulting pyrrolo[1,2-
c]oxazol-3-one. 
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†Dedicated to Prof. Lew Mander on the occasion of his 65th birthday.  Lew, thanks for 
teaching me carbocyclic chemistry. I will never forget the structure of gibberellic acid 
(GA3). 
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Introduction 
While numerous total syntheses of naturally occurring (-)-swainsonine (1)[1] and its 
non-natural enantiomer (+)-swainsonine[2-4] have been reported, these molecules and 
their analogues are still popular targets to develop new synthetic strategies and 
methodologies.  This is partially driven by the ability of (-)-swainsonine to inhibit 
Golgi -mannosidase II, an enzyme involved in the processing of glycoproteins on 
the surface of cancer cells.  This process has been associated with cancer metastasis 
and thus (-)-swainsonine and analogues are potentially useful anti-metastasis drugs for 
the treatment of cancer.[5, 6]  Unfortunately, (-)-swainsonine is not selective for Golgi 
-mannosidase II over other -mannosidases (e.g. lysosomal -mannosidase)[7] 
resulting in undesired side effects (e.g. inhibition of the catabolism of 
oligosaccharides), and thus creating the need for more potent and selective (-)-
swainsonine analogues.  A comprehensive review of the synthesis of swainsonine and 
its analogues was published in 2000 by Nemr.[1]  Since this review seven total 
syntheses of (-)-swainsonine have been reported[8-14] along with several papers 
describing the synthesis of analogues.[14-21] 
Blechert,[12] Carretero[13] and Pyne[14] have each reported a synthesis of (-)-
swainsonine via the syn-dihydroxylation (DH) of the indolizidine derivative 2 
(Scheme 1). 
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Scheme 1 
 
Syn-dihydroxylation of racemic 2 (R = TBS) using catalytic osmium tetraoxide/ 
stoichiometric N-methylmorpholine oxide (NMO) has been reported[22] to give an 88 : 
12 mixture of diols in favour of the desired diastereomer 3 (Scheme 1).  Blechert[12] 
however, found that this method using enantiomerically pure 2 (R = TBS) gave an 
almost equal mixture of the 2 diastereomers. However the use of the Sharpless 
asymmetric dihydroxylation (AD) reaction conditions[23] using AD-mix- gave a 20 : 
1 mixture of diols in favour of the desired diol 3 (R = TBS).  Independently we[14] 
also found that the use of either AD-mix- or AD-mix- on the O-benzyl analogue of 
2 gave the desired diol 3 (R = Bn) in excellent diastereomeric ratios (dr 95 : 5 –98 : 
2).  The stereochemical outcomes for these reactions were consistent with addition of 
the osmium reagent to the less hindered -face of 2. [14, 22] Approach to the -face 
being hindered by the pseudo-axial protons H8a and H3 (Scheme 1).   
While the Sharpless’ AD reagents allowed us access to the desired diol 3 (R = Bn), 
the yields for these reactions were disappointingly low (44-49%).[14]  We suspect that 
this low yield was due to a competing oxidation reaction occurring at the tertiary 
nitrogen atom of 2 (R = Bn) or 3 (R = Bn).  In view of this difficulty we have recently 
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examined pyrrolo[1,2-c]oxazol-3-ones (e.g. 4) as more suitable bicyclic substrates to 
control the DH of substituted pyrrolidines and to simultaneously protect the nitrogen 
atom from oxidation.[24, 25]  For example, the unsubstituted pyrrolo[1,2-c]oxazol-3-one 
4 underwent DH with catalytic osmium tetraoxide to give exclusively the diol 5 in 
good yield (Scheme 2).  This diol resulted from attack of the oxidizing agent from the 
concave face of the molecule (Figure 1) due to the pseudo-axial protons H5 and H7a 
that sterically hinder the -face to attack by the osmium reagent (Figure 1).[24]  This 
argument is similar to that proposed to account for the facial selectivity of DH 
reactions on the related indolizines 2 (Scheme 1).  This methodology allowed the 
diastereoselective synthesis of the triol 6 having the desired relative stereochemistry 
required for the synthesis of swainsonine.[24] In this paper we report the application of 
this methodology to the synthesis of (-)-swainsonine 1 (Schemes 3 and 5). 
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Figure 1. Stereochemical model of 4 (Spartan PC AM1). 
 
Results and Discussion 
The requist pyrrolo[1,2-c]oxazol-3-one 11 was prepared according to Scheme 3 from 
the vinyl epoxide (R, S)-7 (ee 92%) that was used in our earlier synthesis of (-)-
swainsonine.[14]  Aminolysis of 7 with allylamine in the presence of lithium triflate 
with microwave heating at 110oC for 1 h[26] gave the desired amino alcohol 8 in 88% 
yield.  While this compound had been prepared previously by us using conventional 
heating in a sealed tube using acid catalysis (0.1 equiv of p-TsOH, 105oC, 5 days) this 
method was a significant improvement in terms of reaction time. The amino alcohol 8 
was converted to the N-Boc 2,5-dihydropyrrole 10 as described by us earlier.[14]  
Upon treatment with sodium hydride in toluene solution at 50oC compound 10 was 
converted to the desired pyrrolo[1,2-c]oxazol-3-one 11 in 74% yield. Other solvents 
were much less effective in this transformation, for example the use of THF and DMF 
resulted in very poor conversions.  We suspect that the sodium tert-butoxide that is 
generated in these reactions can react reversibly with 11 giving an equilibrium 
mixture of 10 and 11.  In toluene, however, sodium tert-butoxide would be expected 
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to be less soluble forcing the equilibrium to favour the desired ring-closed product 11. 
Alternatively 11 could be prepared by first treatment of the amino alcohol 8 with 
triphosgene in the presence of base (Et3N) to give the oxazolidinone 16 in 77% yield.  
Treatment of 16 with Grubbs I catalyst (benzylidene 
bis(tricyclohexylphosphine)dichlororuthenium)[24] in refluxing dichloromethane 
solution for 18 h gave 11 in 77% yield (Scheme 4).  
With the pyrrolo[1,2-c]oxazol-3-one 11 in hand we next examined its DH reactions,  
the results of this study are summarized in Table 1.  To this end 11 was treated with 
catalytic potassium osmate.dihydrate (K2OsO4.2H2O) and stoichiometric NMO in 
acetone-water,[14] which gave a 3 : 1 inseparable mixture of the diols 12 and 13 from 
1H NMR analysis (Scheme 3).[27]  Complete conversion was obtained within 18 h at 
RT giving an 85 % yield.  A pure sample of the major diol 12 (m.p. 146 oC, []D25 -
31.0 (c 1.77, CHCl3)) was isolated by careful crystallisation from hot dichloromethane 
and petroleum spirit.  This crystallisation was not necessary however, because 
benzylation of the mixture of diols, gave the corresponding bis-benzyl ethers 14 and 
15 in quantitative yield, and these were readily separable by column chromatography.  
Conducting the same DH reaction at 0oC resulted in an improved diastereoselectivity 
and yield (3.5 : 1 and 92 %, respectively).  Thus the diastereoselectivities for the DH 
reaction of 11 were similar to those found for the DH reactions of indolizidine 2.  
These DH reactions however were far less diastereoselective than those of the 
unsubstituted pyrrolo[1,2-c]oxazol-3-one 4. The C-1 -substituent present in 11 is 
most likely responsible for this reduced -face diastereoselectivity.  With the aim of 
increasing the steric bulk of the oxidant, and perhaps the diastereoselectivity, the DH 
reaction was repeated in the presence of the coordinating ligand pyridine (10 equiv.). 
Unfortunately, the use of pyridine extended the reaction time to 7 d and resulted in a 
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significant reduction in the diastereoselectivity to 1.5 : 1 (Table 1).  When AD-mix- 
was used at RT the reaction did not go to completion within 6 d, and the 
diastereoselectivity was only slightly improved (3.7 : 1).  Surprisingly, when AD-mix-
 was used a 20 : 1 ratio of diastereoisomers was obtained, albeit at low conversion 
after 6 days at RT, giving a 46 % yield of product diols 14 and 15 (and 45 % 
recovered starting material). We attribute the disparencies between the  and  AD-
mixes to be a result of a matched/mismatched situation.[23]   
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Scheme 3. Reagents (a) CH2=CHCH2NH2, LiOTf, microwave, 110 
oC, 1 h (88 %); 
(b) Boc2O, NEt3, THF, RT, 24 h (98 %); (c) Grubbs' cat., DCM, reflux, 18 h (95 %); 
(d) NaH, toluene, 50oC, 24 h (74 %); (e) dihydroxylation (see Table 1); (f) NaH, 
BnBr, n-Bu4NI, THF, RT, 2 d (100 %). 
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Scheme 4. Reagents (a) triphosgene, NEt3, CH2Cl2, 0 
oC, 2 h (77 %); (b) Grubbs' cat., 
DCM, reflux, 18 h (77 %). 
 
Table 1 - Summary of results for the dihydroxylation reactions of 11. 
aSee references 14 and 25 for general experimental procedures 
Conversion of 14 into (-)-swainsonine proved to be relatively straight forward. 
(Scheme 5).  Hydrolysis of the oxazolidinone with NaOH in MeOH-water[25] gave the 
amino alcohol 17 in good yield (84 %).  We thought it prudent to protect the 
secondary alcohol of 17, as it might interfere with the cyclisation of the piperidine 
ring, by providing an alternative nucleophile to the nitrogen atom.  Consequently 17 
was treated with tert-butylchlorodiphenylsilane (TBDPSCl) and imidazole at 60oC to 
give the silyl ether 18 in 97 % yield.  Oxidative removal of the O-PMB protecting 
group was then conducted by reaction of 18 with ceric(IV) ammonium nitrate (CAN), 
Reagenta Reaction 
temp. 
(oC) 
Combined 
yield (%) 
of 12 + 13 
Recovered 
11 (%) 
Ratio 
12 : 13 
Reaction 
time 
(days) 
K2OsO4.2H2O/NMO RT 85 - 3 : 1 1 
K2OsO4.2H2O/NMO 0 92 - 3.5 : 1 2 
K2OsO4.2H2O/NMO, 
Pyridine (10 equiv.) 
RT 90 5 1.5 : 1 7 
AD-mix- RT 24 56 3.7 : 1 6 
AD-mix- RT 46 45 20 : 1 6 
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giving the amino alcohol 19 in 92% yield.[14,25]  Cyclization of 19 by activation of the 
primary hydroxyl and then intramolecular N-alkylation (Ph3P, CBr4, Et3N)
[14] gave the 
indolizidine derivative 20 in excellent yield (93%).  Deprotection of the silyl ether by 
reaction with tetra-n-butylammonium fluoride (TBAF) was slow, requiring 5 days to 
complete, however the desired alcohol 21 was obtained in 76 % yield.  Finally the two 
benzyl ethers were removed by catalytic hydrogenolysis under acidic conditions 
(PdCl2, H2) and the resulting product was purified and neutralised by ion-exchange 
chromatography to give (-)-swainsonine 1 in excellent overall yield (93%) and purity.  
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Scheme 5.  Reagents (a) NaOH, MeOH, H2O, 110 
oC, microwave, 2 h (84 %); (b) 
TBDPSCl, imidazole, 65oC, 3 d (97 %); (c) CAN, CH3CN, H2O, RT, 3 h (92 %); (d) 
PPh3, CBr4, NEt3, CH2Cl2, 0
oC, 16 h (93 %); (e) TBAF, THF, RT, 5 d (76 %); (f) 
PdCl2, H2 (1 atm), MeOH, RT, 2 h; ion-exchange (93 %). 
 
This synthetic compound had identical 1H and 13C NMR spectra and TLC mobility 
to an authentic sample of (-)-swainsonine[28] and had a specific rotation, []D26 -71, (c 
0.56, MeOH) [lit.[29] []D26 -82.6, (c 1.03, MeOH); lit.[8] []D23 -86, (c 0.30, MeOH); 
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lit.[30] []D23 -74, (c 0.98, MeOH); lit.[31] []D26 –85.5, (c 0.42, MeOH); lit.[32] []D23 –
87.2, (c 2.1, MeOH)] that was consistent with the enantiomeric purity of its precursor 
7. 
 
Conclusion 
In conclusion, an alternative synthetic strategy has been developed that allows the 
synthesis of (-)-swainsonine. The oxazolidinone group has been found to be a useful 
protecting group in the RCM reaction and, as part of a pyrrolo[1,2-c]oxazol-3-one 
ring system, has functioned as a stereodirecting group in the syn-DH reaction. 
Experimental 
Full details are available as supplementary data that are available on the web 
(http://www.publish.csiro.au/journals/ajc). 
Acknowledgment. We thank the Australian Research Council for financial support 
and the University of Wollongong for a PhD scholarship to K. B. L.  We thank Dr. 
Reg Smith from Phytex, Australia for an authentic sample of (-)-swainsonine. 
References 
 [1] A. E. Nemr, Tetrahedron 2000, 56, 8579. 
[2] B. Davis, A. A. Bell, R. J. Nash, A. A. Watson, R. C. Griffiths, M. G. Jones, C. 
Smith, G. W. J. Fleet, Tetrahedron Lett.  1996, 37, 8565. 
[3] J. P. Shivlock, J. R. Wheatley, R. J. Nash, A. A. Watson, R. C. Griffiths, T. D. 
Butters, M. Müller, D. J. Watkin, D. A. Winkler, G. W. J. Fleet, J. Chem. Soc., Perkin 
Trans. 1.  1999, 37, 2735. 
[4] T. Oishi, T. Iwakuma, M. Hirama, S. Itô, Synlett 1995, 404. 
[5] P. E. Goss, M. A. Baker, J. P. Carver, J. W. Dennis, Clin. Cancer Res. 1995, 1, 
935. 
 11 
[6] P. E. Goss, C. L. Reid, D. Bailey, J. W. Dennis, Clin. Cancer Res. 1997, 3, 1077. 
[7] P. R. Dorling, C. R. Huxtable, S. M. Colegate, Biochem. J. 1980, 191, 649. 
[8] H. Zhao, S. Hans. X. Cheng, D. R. Mooto, J. Org. Chem. 2001, 66, 1761. 
[9] B. M. Trost, D. E. Patterson, Chem. Eur. J. 1999, 5, 3279. 
[10] T. Punniyamurthy, R. Irie, T. Katsuki, Chirality, 2000, 12, 464. 
[11] W. H. Pearson, Y. Ren, J. D. Powers, Heterocycles 2002, 58, 421. 
[12] N. Buschmann, A. Rückert, S. Blechert, J. Org. Chem. 2002, 67, 4325. 
[13] J. de Vicente, R. G. Arrayás, J. Caňada, J. C. Carretero, Synlett 2000, 53. 
[14] K. B. Lindsay, S. G. Pyne, J. Org. Chem. 2002, 67, 7774. 
[15] H. Razavi, R. Polt, J. Org. Chem.  2000, 65, 5963. 
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[17] P. Diaz-Pérez, M. I. Garcia-Moreno, C. Ortiz Mellet, J. M. Garcia Fernández, 
Synlett 2003, 341. 
[18] W. H. Pearson. L. Guo, Tetrahedron Lett. 2001, 42, 8267. 
[19] W. H. Pearson, E. J. Hembre, Tetrahedron Lett. 2001, 42, 8273. 
[20] W. H. Pearson, L. Guo, T. M. Jewell, Tetrahedron Lett.  2002, 43, 2175. 
[21] For a recent review see: S. G. Pyne, Current Org. Syn. 2004, in press. 
[22] C. Mukai, Y.-i. Sugimoto, K. Miyazawa, S. Yamaguchi, M. Hanaoka, J. Org. 
Chem. 1998, 63, 6281. 
[23] H. C. Kolb, M. S. Van Nieuwenhze, K. B. Sharpless, Chem. Rev. 1994, 94, 2483. 
[24] A. S. Davis, N. J. Gates, K. B. Lindsay, M. Tang, S. G. Pyne, Synlett 2004, 49. 
[25] M. Tang, S. G. Pyne, J. Org. Chem. 2003, 68, 7818. 
[26] K. B. Lindsay, M. Tang, S. G. Pyne, Synlett 2002, 731. 
[27] The structure of 15, and hence 13, was established by its formation, as a by-
product, in the benzylation of compound 17 in reference 14. 
 12 
[28] Kindly provided by Dr. Reg Smith, from Phytex Australia, Sydney. 
[29] M. Naruse, S. Aoyagi, C. Kibayashi, C. J. Org. Chem. 1994, 59, 1538. 
[30] W. H. Pearson, E. J. Hembre, J. Org. Chem. 1996, 61, 7217.  
[31] J. A. Hunt, W. R. Roush, J. Org. Chem. 1997, 62, 1112. 
[32] M. J. Schneider, F. S. Ungemach, H. P. Broquist, T. M. Harris, Tetrahedron, 
1983, 39, 29. 
 
 
 
 
GRAPHICAL ABSTRACT 
 
Asymmetric Synthesis of (-)-Swainsonine  
Karl B. Lindsay and Stephen G. Pyne 
 
A new synthesis of (-)-swainsonine via the ring-closing metathesis reaction of a 
substituted 3-allyl-4-vinyl-2-oxazolindinone and subsequent diastereoselective syn-
dihydroxylation of the resulting pyrrolo[1,2-c]oxazol-3-one is described. 
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